Skip to main content
Figure 1 | Stem Cell Research & Therapy

Figure 1

From: Eyes open to stem cells: safety trial may pave the way for cell therapy to treat retinal disease in patients

Figure 1

Stargardt's macular dystrophy. (a) Fundus of a patient with advanced Stargardts disease. There are widespread white/yellow deposits at the posterior pole, indicating lipofuscin, RPE deposits and degeneration of the photoreceptors. Of note is the advanced foveal pigmentation at the centre of the macula (arrow). (b) A red free image showing extensive degeneration in the fovea and hyperfluorescent lipofuscin in RPE (arrows). (c,d) Ocular coherence tomography of a 30-year-old Stargardt's patient with vision of 6/36. There is extensive loss of cone photoreceptors evident in the fovea (arrow). Images courtesy of Miss Giuliana Silvestri.

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512